High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.

Brane Grambozov (First author), Markus Stana (Co-author), Bernhard Kaiser, Josef Karner (Co-author), Sabine Gerum (Co-author), Elvis Ruznic, Barbara Zellinger (Co-author), Raphaela Moosbrugger, Michael Studnicka (Co-author), Gerd Fastner (Co-author), Felix Sedlmayer (Co-author), Franz Zehentmayr* (Last author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Web of Science)
Original languageEnglish
JournalCancers
Volume14
Issue number3
DOIs
Publication statusPublished - 2022

Keywords

  • CELL LUNG-CANCER
  • STEREOTACTIC BODY RADIOTHERAPY
  • PROTON-BEAM THERAPY
  • STAGE-III NSCLC
  • RADIATION-THERAPY
  • RADICAL RADIOTHERAPY
  • CLINICAL-OUTCOMES
  • TOXICITY
  • SURVIVAL
  • PREDICTORS

Cite this